- Home
- THCH vs PMVP Comparison
THCH vs PMVP Comparison
Compare THCH & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THCH
- PMVP
- Stock Information
- Founded
- THCH 2018
- PMVP 2013
- Country
- THCH China
- PMVP United States
- Employees
- THCH N/A
- PMVP N/A
- Industry
- THCH Blank Checks
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- THCH Finance
- PMVP Health Care
- Exchange
- THCH Nasdaq
- PMVP Nasdaq
- Market Cap
- THCH 84.8M
- PMVP 77.4M
- IPO Year
- THCH N/A
- PMVP 2020
- Fundamental
- Price
- THCH $2.49
- PMVP $1.41
- Analyst Decision
- THCH
- PMVP Strong Buy
- Analyst Count
- THCH 0
- PMVP 1
- Target Price
- THCH N/A
- PMVP $5.00
- AVG Volume (30 Days)
- THCH 22.0K
- PMVP 465.9K
- Earning Date
- THCH 08-26-2025
- PMVP 11-06-2025
- Dividend Yield
- THCH N/A
- PMVP N/A
- EPS Growth
- THCH N/A
- PMVP N/A
- EPS
- THCH N/A
- PMVP N/A
- Revenue
- THCH $187,316,342.00
- PMVP N/A
- Revenue This Year
- THCH N/A
- PMVP N/A
- Revenue Next Year
- THCH N/A
- PMVP N/A
- P/E Ratio
- THCH N/A
- PMVP N/A
- Revenue Growth
- THCH N/A
- PMVP N/A
- 52 Week Low
- THCH $1.95
- PMVP $0.81
- 52 Week High
- THCH $5.15
- PMVP $1.82
- Technical
- Relative Strength Index (RSI)
- THCH 39.96
- PMVP 47.46
- Support Level
- THCH $2.48
- PMVP $1.37
- Resistance Level
- THCH $2.60
- PMVP $1.59
- Average True Range (ATR)
- THCH 0.13
- PMVP 0.10
- MACD
- THCH 0.01
- PMVP -0.01
- Stochastic Oscillator
- THCH 33.70
- PMVP 18.10
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under single reportable segment, Tim Hortons. The company's revenue is derived from its operations in the PRC.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.